ArticleSexually transmitted infections2007
Update on lymphogranuloma venereum in the United Kingdom.
Article in Sexually transmitted infections, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Chlamydia (uncomplicated, genital).BMJ clinical evidence · 2015Pooled it
- The association between lymphogranuloma venereum and HIV among men who have sex with men: systematic review and meta-analysis.BMC infectious diseases · 2011Pooled it
- Chlamydia (uncomplicated, genital).BMJ clinical evidence · 2010Pooled it
- Chlamydia (uncomplicated, genital).BMJ clinical evidence · 2008Pooled it
- Trial
- Article
- Chlamydia and lymphogranuloma venereum in Canada: 2003-2012 Summary Report.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2015Article
- Lymphogranuloma venereum: diagnostic and treatment challenges.Infection and drug resistance · 2015Review
- Rapid determination of lymphogranuloma venereum serovars of Chlamydia trachomatis by quantitative high-resolution melt analysis (HRMA).Journal of clinical microbiology · 2012Article
- Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2010Review
- Sexual history: its importance in averting detrimental misdiagnosis and delayed diagnosis.BMJ case reports · 2009Article
- Focus on Chlamydia.Sexually transmitted infections · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis report updates the UK epidemiology of lymphogranuloma venereum (LGV) to the end of April 2007.
methodsThe Health Protection Agency's Centre for Infections undertakes laboratory testing for LGV and subsequent epidemiological investigation of cases after laboratory confirmation of the LGV serovars (L1-3). Data analysis of enhanced surveillance and laboratory reports was undertaken.
resultsFrom October 2004 to end April 2007, 492 cases of LGV have been diagnosed and enhanced surveillance forms have been returned for 423. Cases peaked in the third quarter of 2005 with an average of 32 cases per month, while in 2006 this fell to 12 cases per month. Nationally, the outbreak is focused in London, Brighton and the North West. All cases are in men, 99% of whom are MSM, with a median age of 40 and predominantly white ethnicity (91%). Co-infection remains considerable: HIV (74%); hepatitis C (14%); syphilis (5%); and other STIs including gonorrhoea, genital herpes and hepatitis B. The number of men reporting greater than 10 sexual contacts in the previous 3 months has reduced from 23% (47) to 13% (15) from 2005-2006. DISCUSSION: The epidemic continues in the mostly white MSM population of the UK. The demographics of LGV remain similar to those previously described and high levels of HIV co-infection continue. Reduced numbers of sexual contacts might be contributing to the reduced numbers of LGV seen in 2006 but could simply mean that LGV is moving out of the highest risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.